Shankar Balasubramanian

Sir Shankar Balasubramanian (born 30 September 1966) is an Indian-born British chemist and Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College, Cambridge. He is recognised for his contributions in the field of nucleic acids. He is scientific founder of Solexa and biomodal (formally Cambridge Epigenetix). Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Shankar Balasubramanian', query time: 0.01s Refine Results
  1. 1
    KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency

    KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency by Samah W. Awwad, Colm Doyle, Josie Coulthard, Aldo S. Bader, Nadia Gueorguieva, Simon Lam, Vipul Gupta, Rimma Belotserkovskaya, Tuan-Anh Tran, Shankar Balasubramanian, Stephen P. Jackson

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: